BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4757404)

  • 1. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
    Kauko K; Viukari M
    Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the excretion curves of 2 lithium salt preparations: carbonate slow-release sulfate (pharmacological and statistical study)].
    Rutigliano G; Chieppa M; Leonetti S
    Acta Neurol (Napoli); 1974; 29(1):77-92. PubMed ID: 4828165
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of serum levels of two sustained-release preparations of lithium carbonate.
    Shaw DM; Hewland R; Johnson AL; Hilary-Jones P; Howlett MR
    Curr Med Res Opin; 1974; 2(2):90-4. PubMed ID: 4828627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical administration of lithiumaspartate].
    Consbruch U; Orth M; Degkwitz R
    Arzneimittelforschung; 1974 Aug; 24(8):1077-9. PubMed ID: 4479527
    [No Abstract]   [Full Text] [Related]  

  • 5. Slow-release lithium carbonate.
    Coppen A; Bailey JE; White SG
    J Clin Pharmacol J New Drugs; 1969; 9(3):160-2. PubMed ID: 5255180
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience in the treatment of manic-depressive states with orally administered enteric-coated lithium carbonate tablets].
    Ishida M; Orihashi Y; Igarashi A; Kakita Y; Takeuchi A
    Iryo; 1972 Mar; 26(3):229-37. PubMed ID: 5027291
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of plasma lithium levels and their interindividual variations with coated lithium carbonate tablets and a medium-slow-release lithium sulphate preparation (Lithionit Duretter).
    Persson G
    Acta Psychiatr Scand; 1977 Feb; 55(2):147-52. PubMed ID: 320831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the dissolution rate of lithium tablets on side-effect.
    Borg KO; Jeppsson J; Sjögren J
    Acta Pharm Suec; 1974 May; 11(2):133-40. PubMed ID: 4609300
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of contemnol tablets (lithium retard Spofa)].
    König L; Lange E
    Psychiatr Neurol Med Psychol (Leipz); 1987 Apr; 39(4):230-3. PubMed ID: 3110815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium lipett C) and lithium carbonate tablets.
    Persson G
    Acta Psychiatr Scand; 1974; 50(2):174-82. PubMed ID: 4853671
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of standard and slow-release oral lithium carbonate products.
    Wallis J; Miller R; McFadyen ML; Carlile JB
    S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic properties of the delayed-action form of lithium carbonate].
    Kabes J; Kabesová L
    Cesk Psychiatr; 1983 Apr; 79(2):102-6. PubMed ID: 6407766
    [No Abstract]   [Full Text] [Related]  

  • 16. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
    Caldwell HC; Westlake WJ; Connor SM; Flanagan T
    J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-dose bioavailability of two extended-release lithium carbonate products.
    Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
    Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of side effects with coated lithium carbonate tablets and lithium sulphate preparations giving medium-slow and slow-release.
    Edström A; Persson G
    Acta Psychiatr Scand; 1977 Feb; 55(2):153-8. PubMed ID: 320832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does the patient prefer his lithium treatment?
    Vestergaard P
    Pharmacopsychiatry; 1985 May; 18(3):223-4. PubMed ID: 4011670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.